Now, what the links you posted DO NOT state is that:
Patients also experienced a marked increase in levels of antibodies against tissue transglutaminase and deamidated gliadin peptides between baseline and day 14, although this did not reach statistical significance. Levels continued to rise after the challenge was completed.
The researchers observe that the timing of intestinal changes did not significantly correlate with those of serology, symptoms, or LAMA.
"If we accept that duodenal mucosal damage is the gold standard marker of coeliac disease activity, then it is clear that, despite out encouraging findings, improved non-invasive markers of coeliac disease activity are greatly needed for use in patient management and clinical research," emphasize Leffler et al writing in Gut.
Finally, noting that a minority of patients had no significant response to the 2-week gluten challenge, and that gluten sensitivity varied significantly among the group, they conclude: "An accurate, non-invasive measure of coeliac disease activity would be valuable in many respects and may allow the strictness of the gluten-free diet to be personalised without negative consequences. "
The above from: http://www.medwire-n...c_response.html
The op stated that they are going to the lab in 2 - 3 weeks for the test. Well, that obviously means the blood panel not an endoscopy w/ biopsy. So, the study you reference is not applicable in this particular instance.
The researchers themselves admit the need for improved, accurate, non invasive markers for ceilac disease.
And I think ALL of us will agree on that point.